Project background

Advancing the Frontiers of Bioelectronics and Synthetic Biology

Our group integrates state‑of‑the‑art synthetic biology with advanced nanotechnology and electrogenetic interfaces to engineer human cells for next‑generation bioelectronic medicine, designing programmable cells that respond to electrical, electromagnetic, acoustic and biochemical cues to achieve wireless, real‑time control of therapeutic protein expression and metabolic regulation. Leveraging innovative platforms such as direct‑current‑actuated regulation, electromagnetic programming of wireless expression, and closed‑loop systems, we aim to translate these technologies into clinically relevant, minimally invasive therapies for cancer, as well as metabolic, neurodegenerative, autoimmune and infectious diseases.

Job description

• Postdoctoral projects will combine catalyst engineering, computational simulation, bioelectrode device fabrication, and ele...